Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 Oct;455(1):105-13.
doi: 10.1007/s00424-007-0292-5. Epub 2007 Jul 11.

Phosphatidylinositol 4,5-bisphosphate interactions with the HERG K(+) channel

Affiliations
Review

Phosphatidylinositol 4,5-bisphosphate interactions with the HERG K(+) channel

Jin-Song Bian et al. Pflugers Arch. 2007 Oct.

Abstract

Regulation of ion channel activity plays a central role in controlling heart rate, rhythm, and contractility responses to cardiovascular demands. Dynamic beat-to-beat regulation of ion channels is precisely adjusted by autonomic stimulation of cardiac G protein-coupled receptors. The rapidly activating delayed rectifier K(+) current (I (Kr)) is produced by the channel that is encoded by human ether-a-gogo-related gene (HERG) and is essential for the proper repolarization of the cardiac myocyte at the end of each action potential. Reduction of I (Kr) via HERG mutations or drug block can lead to lethal cardiac tachyarrhythmias. Autonomic regulation of HERG channels is an area of active investigation with the emerging picture of a complex interplay of signal transduction events, including kinases, second messengers, and protein-protein interactions. A recently described pathway for regulation of HERG is through channel interaction with the phospholipid phosphatidylinositol 4,5-bisphosphate (PIP2). Changes in cellular PIP2 concentrations may occur with Gq-coupled receptor activation. Here, we review the evidence for PIP2-HERG interactions, its potential biological significance, and unfilled gaps in our understanding of this regulatory mechanism.

PubMed Disclaimer

References

    1. J Biol Chem. 2002 May 24;277(21):18528-34 - PubMed
    1. Br J Cancer. 2000 Dec;83(12):1722-9 - PubMed
    1. J Physiol. 1998 Sep 1;511 ( Pt 2):333-46 - PubMed
    1. Cancer Res. 2002 Sep 1;62(17):4843-8 - PubMed
    1. Mol Pharmacol. 1999 Mar;55(3):497-507 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources